Q1 Revenue drops 36% YoY to ₹0.83 Cr; Net Profit declines to ₹8.03 Lakhs
Desh Rakshak Aushdhalaya reported a weak start to FY27, with Q1 revenue from operations falling 36.3% YoY to ₹82.83 Lakhs. On a sequential basis, the performance saw a sharp contraction of 76% compared to the ₹3.45 Cr revenue reported in the March 2026 quarter. Net profit for the quarter stood at ₹8.03 Lakhs, down 16.3% from ₹9.59 Lakhs in the same period last year. The company remains a micro-cap entity with high volatility in its quarterly financial performance.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company reported its first-quarter results for FY27, showing a significant contraction in both revenue and profitability compared to both the previous year and the preceding quarter.
ஏன் இது முக்கியம்For a company with annual revenues of only ~₹7 Cr, a 36% YoY drop in quarterly revenue is material and suggests challenges in maintaining sales momentum or distribution reach.
Revenue (Q1 FY27): ₹82.83 லட்சம்Revenue Growth (YoY): -36.3%Net Profit (Q1 FY27): ₹8.03 லட்சம்Q1 வருவாய் vs TTM வருவாய்: ~11.8%EPS (Q1 FY27): ₹0.14
📅 குறுகிய காலம்The stock may face downward pressure in the short term as the market reacts to the sharp decline in top-line and bottom-line performance.
📈 நீண்ட காலம்Limited structural significance unless the company can demonstrate a path to scaling its Ayurvedic medicine business beyond its current small revenue base.
⚠ அபாய எச்சரிக்கைகள்
- Significant sequential revenue volatility
- Micro-cap liquidity risk
- High client/market concentration in a single segment (Ayurvedic Medicines)
👀 கவனிக்க வேண்டியவை
Investors should monitor whether the sharp sequential revenue drop (76% vs Q4 FY26) is a seasonal trend or a structural decline in demand for its Ayurvedic products. Given the micro-cap nature (₹14 Cr market cap), liquidity and earnings volatility remain high risks.
